Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 102
12
Diseases
35
Unique genes
0.258
Avg. similarity score
Congenital hypothyroidism
Most-connected disease (8 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congenital hypothyroidism
Congenital hypothyroidism without goiter
Congenital thyroid atrophy
Thyroid agenesis
Congenital hypothyroidism due to absence of thyroid gland
Testicular disease
X-linked central congenital hypothyroidism with late-onset testicular enlargement
Spermatocele
Thyroid dyshormonogenesis
Genetic transient congenital hypothyroidism
Iodide peroxidase deficiency
Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital hypothyroidism | 8 | 8 | 14 |
| Congenital hypothyroidism without goiter | 7 | 7 | 6 |
| Congenital thyroid atrophy | 7 | 7 | 6 |
| Thyroid agenesis | 6 | 6 | 7 |
| Congenital hypothyroidism due to absence of thyroid gland | 5 | 5 | 4 |
| Testicular disease | 5 | 5 | 14 |
| X-linked central congenital hypothyroidism with late-onset testicular enlargement | 5 | 5 | 1 |
| Spermatocele | 3 | 3 | 8 |
| Thyroid dyshormonogenesis | 3 | 3 | 7 |
| Genetic transient congenital hypothyroidism | 2 | 2 | 1 |
| Iodide peroxidase deficiency | 2 | 2 | 1 |
| Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PAX8 | 7 / 12 | Congenital hypothyroidism, Congenital hypothyroidism due to absence of thyroid gland, Congenital hypothyroidism without goiter, Congenital thyroid atrophy and 3 more |
| IGSF1 | 6 / 12 | Congenital hypothyroidism, Congenital hypothyroidism without goiter, Congenital thyroid atrophy, Testicular disease and 2 more |
| NKX2-5 | 5 / 12 | Congenital hypothyroidism, Congenital hypothyroidism due to absence of thyroid gland, Congenital hypothyroidism without goiter, Congenital thyroid atrophy and 1 more |
| TSHR | 5 / 12 | Congenital hypothyroidism, Congenital hypothyroidism due to absence of thyroid gland, Congenital hypothyroidism without goiter, Congenital thyroid atrophy and 1 more |
| THRA | 4 / 12 | Congenital hypothyroidism, Congenital hypothyroidism without goiter, Congenital thyroid atrophy, Thyroid agenesis |
| TSHB | 4 / 12 | Congenital hypothyroidism, Congenital hypothyroidism without goiter, Congenital thyroid atrophy, Thyroid agenesis |
| DUOX2 | 3 / 12 | Congenital hypothyroidism, Genetic transient congenital hypothyroidism, Thyroid dyshormonogenesis |
| SLC26A4 | 3 / 12 | Congenital hypothyroidism, Congenital hypothyroidism due to absence of thyroid gland, Thyroid agenesis |
| TPO | 3 / 12 | Congenital hypothyroidism, Iodide peroxidase deficiency, Thyroid dyshormonogenesis |
| DUOXA2 | 2 / 12 | Congenital hypothyroidism, Thyroid dyshormonogenesis |
| IYD | 2 / 12 | Congenital hypothyroidism, Thyroid dyshormonogenesis |
| PPP3CA | 2 / 12 | Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development, Testicular disease |
| SLC5A5 | 2 / 12 | Congenital hypothyroidism, Thyroid dyshormonogenesis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Thyroid hormone synthesis | KEGG | 10 / 75 | 45.8× | 7.85e-15 | 2.53e-12 ✓ sig. |
| Thyroxine biosynthesis | Reactome | 5 / 7 | 245× | 3.26e-12 | 6.41e-10 ✓ sig. |
| Autoimmune thyroid disease | KEGG | 5 / 54 | 31.8× | 4.46e-7 | 2.42e-5 ✓ sig. |
| Multifunctional anion exchangers | Reactome | 2 / 9 | 76.3× | 2.93e-4 | 5.27e-3 ✓ sig. |
| Glycoprotein hormones | Reactome | 2 / 12 | 57.2× | 5.35e-4 | 8.39e-3 ✓ sig. |
| Hormone ligand-binding receptors | Reactome | 2 / 12 | 57.2× | 5.35e-4 | 8.39e-3 ✓ sig. |
| Defective SLC26A4 causes Pendred syndrome (PDS) | Reactome | 1 / 1 | 343× | 2.91e-3 | 3.01e-2 ✓ sig. |
| Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1) | Reactome | 1 / 1 | 343× | 2.91e-3 | 3.01e-2 ✓ sig. |
| G alpha (s) signalling events | Reactome | 3 / 140 | 7.4× | 7.73e-3 | 5.83e-2 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) | Reactome | 2 / 55 | 12.5× | 1.11e-2 | 7.32e-2 |
| Antagonism of Activin by Follistatin | Reactome | 1 / 4 | 85.8× | 1.16e-2 | 7.50e-2 |
| HHAT G278V abrogates palmitoylation of Hh-Np | Reactome | 1 / 4 | 85.8× | 1.16e-2 | 7.50e-2 |
| Regulation of lipolysis in adipocytes | KEGG | 2 / 59 | 11.6× | 1.27e-2 | 7.89e-2 |
| FasL/ CD95L signaling | Reactome | 1 / 5 | 68.6× | 1.45e-2 | 8.53e-2 |
| Long-term potentiation | KEGG | 2 / 67 | 10.2× | 1.62e-2 | 9.12e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| thyroid gland development | GO:0030878 | 6 / 30 | 107× | 1.58e-11 | 5.55e-9 ✓ sig. |
| thyroid hormone generation | GO:0006590 | 5 / 16 | 167× | 7.36e-11 | 2.17e-8 ✓ sig. |
| iodide transport | GO:0015705 | 4 / 8 | 267× | 7.18e-10 | 1.67e-7 ✓ sig. |
| hormone biosynthetic process | GO:0042446 | 3 / 12 | 133× | 1.31e-6 | 1.03e-4 ✓ sig. |
| thyroid-stimulating hormone signaling pathway | GO:0038194 | 2 / 2 | 534× | 3.41e-6 | 2.21e-4 ✓ sig. |
| apoptotic signaling pathway | GO:0097190 | 4 / 84 | 25.4× | 1.79e-5 | 8.22e-4 ✓ sig. |
| cellular response to gonadotropin stimulus | GO:0071371 | 2 / 7 | 153× | 7.11e-5 | 2.35e-3 ✓ sig. |
| copper ion transport | GO:0006825 | 2 / 11 | 97.1× | 1.85e-4 | 4.79e-3 ✓ sig. |
| oxalate transport | GO:0019532 | 2 / 11 | 97.1× | 1.85e-4 | 4.79e-3 ✓ sig. |
| thyroid hormone metabolic process | GO:0042403 | 2 / 13 | 82.1× | 2.62e-4 | 6.12e-3 ✓ sig. |
| sulfate transmembrane transport | GO:1902358 | 2 / 16 | 66.7× | 4.02e-4 | 8.24e-3 ✓ sig. |
| prostate gland development | GO:0030850 | 2 / 16 | 66.7× | 4.02e-4 | 8.24e-3 ✓ sig. |
| hydrogen peroxide catabolic process | GO:0042744 | 2 / 21 | 50.8× | 7.00e-4 | 1.20e-2 ✓ sig. |
| positive regulation of cell motility | GO:2000147 | 2 / 23 | 46.4× | 8.41e-4 | 1.35e-2 ✓ sig. |
| cell-cell signaling | GO:0007267 | 4 / 234 | 9.1× | 9.25e-4 | 1.44e-2 ✓ sig. |